Effect of the anti-neoplastic agents edelfosine (ET-18-OCH3), ilmofosine (BM 41.440) and the hexadecylphosphocholine analogues D-20133 and D-21266 on histamine release from isolated rat mast cells

Immunopharmacology

Volumn 44, Issue 3, 1999, Pages 211-221

  Grosman, Nina ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

BM 41.440 (ilmofosine); D 20133; D 21266; ET 18 OCH3 (edelfosine); Ether phospholipid; Heterocyclic hexadecylphosphocholine analogues; Histamine release; Mast cell

Indexed keywords

1 HEXADECYL 2 METHYLGLYCEROPHOSPHOCHOLINE; ANTIGEN; CALCIMYCIN; COMPOUND 48-80; D 20133; EDELFOSINE; ILMOFOSINE; MILTEFOSINE; OCTADECYL (N,N PIPERIDINIO 4 YL) PHOSPHATE; OCTADECYL [2 (N,N DIMETHYLPIPERIDINO)ETHYL] PHOSPHATE; PERIFOSINE; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HISTAMINE RELEASE; IMMUNOMODULATION; IN VITRO STUDY; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCIMYCIN; HISTAMINE RELEASE; IONOPHORES; MALE; MAST CELLS; PHORBOL ESTERS; PHOSPHOLIPID ETHERS; PHOSPHORYLCHOLINE; PIPERIDINES; RATS; RATS, WISTAR;

EID: 0032783932     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00040-5     Document Type: Article

References (42)

1. 3 on cytosolic calcium and on apoptosis. Br. J. Pharmacol. 121:1997;1364-1368.
2. Arthur G., Bittman R. The inhibition of cell signaling pathways by antitumor ether lipids. Biochim. Biophys. Acta. 1390:1998;85-102.
3. Baburina I., Jackowski S. Apoptosis triggered by 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine is prevented by increased expression of CTP:phosphocholine cytidylyltransferase. J. Biol. Chem. 273:1998;2169-2173.
4. Bartholeyns J., Fozard J.R. Role of histamine in tumor development. Trends Pharmacol. Sci. 6:1985;123-125.
5. Berdel, W.E., Andreesen, R., Munder, P.G., 1986. Synthetic alkyl-phospholipid analogs; A new class of antitumor agents. In: Kuo, J.F. (Ed.), Phospholipids and Cellular Regulation. CRC Press, Boca Raton, FL, Vol. 2, pp. 41-73.
6. 2+ concentration in a normal and a breast cancer cell line. Anticancer Res. 14:1994;1549-1556.
7. Botzler C., Kolb H-J., Issels R.D., Multhoff G. Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells. Int. J. Cancer. 65:1996;633-638.
8. Brachwitz H., Vollgraf C. Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells. Pharmacol. Ther. 66:1995;39-82.
9. 2+ levels. Cell Calcium. 19:1996;383-390.
10. 2-receptor antagonist. Lancet. 2:1988;1369.
11. Diamant B., Grosman N., Skov P.S., Thomle S. Effect of divalent cations and metabolic energy on the anaphylactic histamine release from rat peritoneal mast cells. Int. Arch. Allergy. 47:1974;412-424.
12. Dimitriadou V., Koutsilieris M. Mast cell-tumor cell interactions: for or against tumour growth and metastasis? Anticancer Res. 17:1997;1541-1550.
13. Fauve R.M. Macrophages and cancer. 50th Forum in immunology. Res. Immunol. 144:1993;265-298. organizer.
14. Geilen C.C., Haase R., Buchner K., Wieder T., Hucho F., Reutter W. The phospholipid analogue, hexadecylphosphocholine, inhibits protein kinase C in vitro and antagonises phorbol ester-stimulated cell proliferation. Eur. J. Cancer. 27:1991;1650-1653.
15. Grosman N. The influence of ether lipid (AMG) on histamine release from isolated rat mast cells: synergistic interaction with TPA indicates protein kinase C activation. Immunopharmacology. 20:1990;143-149.
16. Grosman N. Effects of the ether phospholipid AMG-PC on mast cells are similar to that of the ether lipid AMG but different from that of the analogue hexadecylphosphocholine. Immunopharmacology. 22:1991;39-48.
17. 2+-ATPase activity of rat synaptosomes and leukocyte membranes. Immunopharmacology. 40:1998;163-171.
18. Grosman N. On the use of ionophores as probes for calcium signalling. Observations with rat mast cells. Inflammation Res. 48(Suppl. 1):1999;S25-S26.
19. Grosman N., Nielsen K.A. The influence of tetradecanoyl-phorbol-acetate (TPA) on histamine release from isolated rat mast cells. Agents Actions. 24:1988;40-48.
20. Grunicke H.H., Maly K., Überall F., Schubert C., Kindler E., Stekar J., Brachwitz H. Cellular signalling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transduction. Adv. Enzyme Regul. 36:1996;385-407.
21. 3 acts as an activator of protein kinase C in HL-60 cells. FEBS Lett. 290:1991;231-234.
22. Heesbeen E.C., Verdonck L.F., Staal G.E.J., Rijksen G. Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells. Biochem. Pharmacol. 47:1994;1481-1488.
23. Hellstrand K., Hermodsson S., Brune M., Naredi P., Carneskog J., Mellqvist U-H. Histamine in cancer immunotherapy. Scand. J. Clin. Lab. Invest. 57:1997;193-202.
24. Hilgard P., Klenner T., Stekar J., Unger C. Alkylphosphocholines: a new class of membrane-active anticancer agents. Cancer Chemother. Pharmacol. 32:1993;90-95.
25. Hilgard P., Klenner T., Stekar J., Nössner G., Kutscher B., Engel J. D-21266, a new heterocyclic alkylphospholipid with antitumour activity. Eur. J. Cancer. 33:1997;442-446.
26. Hochhuth C.H., Vehmeyer K., Eibl H., Unger C. Hexadecylphosphocholine induces interferon-γ secretion and expression of GM-CSF mRNA in human mononuclear cells. Cell. Immunol. 141:1992;161-168.
27. Houlihan W.J., Lohmeyer M., Workman P., Cheon S.H. Phospholipid antitumor agents. Med. Res. Rev. 15:1995;157-223.
28. Kiss Z., Crilly K.S. Alkyl lysophospholipids inhibit phorbol ester-stimulated phospholipase D activity and DNA synthesis in fibroblasts. FEBS Lett. 412:1997;313-317.
29. Lohmeyer M., Workman P. The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET18-OMe. Biochem. Pharmacol. 45:1993;77-86.
30. Maly K., Überall F., Schubert C., Kindler E., Stekar J., Brachwitz H., Grunicke H.H. Interference of new alkylphospholipid analogues with mitogenic signal transduction. Anti-Cancer Drug Des. 10:1995;411-425.
31. Mandal A., Wang Y., Ernsberger P., Kester M. Interleukin-1-induced ether-linked diglycerides inhibit calcium-insensitive protein kinase C isotypes. Implications for growth senescence. J. Biol. Chem. 272:1997;20306-20311.
32. v/+, W/+ and +/+) grafted with a methylcholanthrene-induced fibrosarcoma: correlation with tumour rejection. Cancer Lett. 85:1994;125-131.
33. Safa O., Parkin S.M., Matthew A.M., Bibby M.C. Morphological and immunological observations on the effects of hexadecylphosphocholine (HPC) in nude mice bearing MT-1 breast cancer xenografts. Anticancer Res. 17:1997;37-44.
34. Schreiber B.M., Layne M.D., Modest E.J. Superoxide production by macrophages stimulated in vivo with synthetic ether lipids. Lipids. 29:1994;237-242.
35. Stekar J., Hilgard P., Voegeli R., Maurer H.R., Engel J., Kutscher B., Nössner G., Schumacher W. Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133. Cancer Chemother. Pharmacol. 32:1993;437-444.
36. Stekar J., Hilgard P., Klenner T. Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide. Eur. J. Cancer. 31A:1995;372-374.
37. Storch J., Ferber E., Munder P.G. Influence of platelet activating factor and a nonmetabolizable analogue on superoxide production by bone marrow derived macrophages. J. Leukocyte Biol. 44:1988;385-390.
38. Tharp M.D., Kasper C., Thiele D., Charley M.R., Kennerly D.A., Sullivan T.J. Studies of connective tissue mast cell-mediated cytotoxicity. J. Invest. Dermatol. 93:1989;423-428.
39. Wieder T., Zhang Z., Geilen C.C., Orfanos C.E., Giuliano A.E., Cabot M.C. The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D. Cancer Lett. 100:1996;71-79.
40. Woolley, D.E., 1993. Tumour cell growth and metastatic spread: an introductory overview. In: Garcia-Caballero, M., Brandes, L.J., Hosoda, S. (Eds.), Histamine in Normal and Cancer Cell Proliferation. Adv. Biosci., Pergamon, Vol. 89, pp. 1-29.
41. Zeisig R., Rudolf M., Eue I., Arndt D. Influence of hexadecylphosphocholine on the release of tumor necrosis factor and nitroxide from peritoneal macrophages in vitro. J. Cancer Res. Clin. Oncol. 121:1995;69-75.
42. Zhou X., Arthur G. 1-O-Octadecyl-2-O-methylglycerophosphocholine inhibits protein kinase C-dependent phosphorylation of endogenous proteins in MCF-7 cells. Biochem. J. 324:1997;897-902.